Clinical Trial: A Pilot Study of the secondary prophylaxtic use of Hetrombopag in preventing Platinum-Based Chemotherapy inducedthrombocytopenia in Lung Cancer Patients (China)

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Pilot Study of the secondary prophylaxtic use of Hetrombopag in preventing Platinum-Based Chemotherapy inducedthrombocytopenia in Lung Cancer Patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130220

Registration Time: 2026/08/17

Type: Interventional study

Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329754

Published by HT Digital Content Services with permission from Health Daily Digest....